Document Detail

Effects of intracoronary nicardipine, diltiazem and verapamil on coronary blood flow.
MedLine Citation:
PMID:  10731269     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Intracoronary (IC) calcium channel blockers (CCB) such as diltiazem and verapamil are frequently utilized during percutaneous coronary interventions to maximize coronary blood flow. Their use, however, may be limited by systemic side effects such as hypotension and bradyarrhythmias. The vasoselective dihydropyridines, such as nicardipine, may be more effective at increasing coronary blood flow with fewer systemic side effects. This study compares the effects of nicardipine, diltiazem and verapamil on coronary blood flow, heart rate and blood pressure. METHODS: IC nicardipine (200 mcg), diltiazem (1 mg) and verapamil (200 mcg) were serially administered in a randomized, double-blinded fashion in minimally diseased (< 30% stenosis) left anterior descending or left circumflex arteries in nine patients. Epicardial coronary artery diameter (ECAD) was determined by quantitative coronary angiography and coronary blood flow velocity (CBFV) was measured by Doppler Flowire in each patient before and after each medication. RESULTS: Nicardipine significantly increased CBFV (p < 0.05) and had a longer duration of effect (p < 0.05), but had no difference in ECAD compared with diltiazem and verapamil. No differences were noted between CCB in changes in heart rate or mean arterial blood pressure. However, two patients had transient episodes of Type I second degree AV block after receiving diltiazem. CONCLUSION: When compared with diltiazem and verapamil, nicardipine appears to offer more potent and more prolonged vasodilatation with less risk of serious systemic side effects. Future studies are needed to assess the efficacy of IC nicardipine in patients with no-reflow.
M D Fugit; B J Rubal; D J Donovan
Related Documents :
20302399 - Measurement of coronary flow response to cold pressor stress in asymptomatic women with...
2924419 - Tissue acidosis: role in sustained arteriolar dilatation distal to a coronary stenosis.
8853389 - Branchial and systemic roles of adenosine receptors in rainbow trout: an in vivo micros...
17145669 - Can the modified allen's test always detect sufficient collateral flow in the hand? a c...
14630989 - Coronary flow reserve in the newborn lamb: an intracoronary doppler guide wire study.
4045029 - Reduction in blood flow in normal and narrowed coronary arteries of dogs by leukotriene...
11435789 - Uncoupling of cerebral blood flow and metabolism after cerebral contusion in the rat.
24866569 - Transmural variation and anisotropy of microvascular flow conductivity in the rat myoca...
12843349 - Assessment of cerebral blood flow by means of blood-flow-volume measurement in the inte...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  The Journal of invasive cardiology     Volume:  12     ISSN:  1042-3931     ISO Abbreviation:  J Invasive Cardiol     Publication Date:  2000 Feb 
Date Detail:
Created Date:  2000-06-06     Completed Date:  2000-06-06     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8917477     Medline TA:  J Invasive Cardiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  80-5     Citation Subset:  IM    
60th Medical Group Hospital, Division of Cardiology, Travis AFB, CA 94535-1800, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Calcium Channel Blockers / administration & dosage*,  therapeutic use
Coronary Circulation / drug effects*
Coronary Disease / drug therapy
Coronary Vessels
Diltiazem / administration & dosage*,  therapeutic use
Double-Blind Method
Middle Aged
Nicardipine / administration & dosage*,  therapeutic use
Verapamil / administration & dosage*,  therapeutic use
Reg. No./Substance:
0/Calcium Channel Blockers; 42399-41-7/Diltiazem; 52-53-9/Verapamil; 55985-32-5/Nicardipine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Coronary stenting without predilatation in a broad spectrum of clinical and angiographic situations.
Next Document:  Vascular complications after percutaneous coronary interventions using abciximab (Reopro ): prospect...